Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript February 15, 2024 Prothena Corporation plc misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-1.23. PRTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and […]
Penserra Capital Management LLC bought a new position in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,104 shares of the biotechnology company’s stock, valued at approximately $211,000. Several other […]
Prothena (NASDAQ:PRTA – Get Free Report) had its target price lowered by JMP Securities from $83.00 to $81.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price target indicates a potential upside of 115.71% from the stock’s previous close. […]
Prothena Co. plc (NASDAQ:PRTA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […]
Prothena (NASDAQ:PRTA – Get Free Report) will release its earnings data after the market closes on Thursday, November 2nd. Analysts expect Prothena to post earnings of ($0.26) per share for the quarter. Prothena (NASDAQ:PRTA – Get Free Report) last announced its quarterly earnings results on Thursday, August 3rd. The biotechnology company reported ($1.03) EPS for […]